New screening tool can identify preeclampsia risk sooner, test maker says

A new blood test is now available in the United States that can assess the risk of preeclampsia in pregnant individuals during their first trimester. The test, developed by Labcorp, is the first of its kind and can be performed between 11 and 14 weeks gestation. However, some doctors question the test’s usefulness and its impact on clinical guidance for preeclampsia. Preeclampsia is a serious pregnancy complication characterized by high blood pressure and organ damage. The new screening test evaluates the risk of preeclampsia by the third trimester and provides a comprehensive risk assessment.